Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
September 27, 2019 14:50 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
August 14, 2019 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Announces CE Mark Approval for Nexus
August 12, 2019 11:20 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Report Fiscal 2019 Fourth Quarter Financial Results and Host Conference Call and Webcast on August 14
August 07, 2019 14:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
July 18, 2019 10:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Announces Inclusion in the Russell 2000® and 3000 Indexes
July 01, 2019 07:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 01, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
SEC Investigation of Misonix, Inc. Ends With No Action
June 20, 2019 11:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., June 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes,...
Misonix Receives U.S. FDA Clearance for Nexus, its Revolutionary Integrated Ultrasonic Surgical Platform
June 03, 2019 07:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29
May 20, 2019 07:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Reports Fiscal 2019 Third Quarter Revenue of $9.6 Million
May 08, 2019 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 08, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...